Comparison of viscoelastic substances used in phacoemulsification
- PMID: 9041089
- DOI: 10.1016/s0886-3350(96)80198-2
Comparison of viscoelastic substances used in phacoemulsification
Abstract
Purpose: To evaluate the usefulness of four viscoelastic agents during phacoemulsification: 2% hydroxypropylmethylcellulose (HPMC) (Methocel), 3% sodium hyaluronate with 4% chondroitin sulfate (Viscoat), 1% sodium hyaluronate (Healon), 1.4% sodium hyaluronate (Healon GV).
Setting: Eye Clinic, Kreiskrankenhaus Bad Hersfeld, Germany.
Methods: Two hundred patients, divided into four groups of 50 patients, received one of the viscoelastic substances during phacoemulsification and posterior chamber intraocular lens implantation. Patients were followed for 1 month. Visual acuity and intraocular pressure (IOP) were measured. The following were subjectively evaluated for each viscoelastic: corneal findings, anterior chamber reaction, visibility of intraocular structures and retention time during phacoemulsification, space maintaining ability, and removability and ease of injection.
Results: Postoperative IOP and visual acuity were comparable among the four groups. Viscoat tended to trap nuclear fragments and air bubbles during the phacoemulsification procedure, which decreased visibility during surgery. Space maintenance and injection ease were significantly better with Healon and Healon GV.
Conclusion: The high molecular weight viscoelastics (Healon and Healon GV) performed better as viscosurgical tool during cataract surgery using phacoemulsification.
Similar articles
-
Corneal endothelial protection by different viscoelastics during phacoemulsification.J Cataract Refract Surg. 1997 Apr;23(3):433-9. doi: 10.1016/s0886-3350(97)80190-3. J Cataract Refract Surg. 1997. PMID: 9159690 Clinical Trial.
-
Effect of Healon5 and 4 other viscoelastic substances on intraocular pressure and endothelium after cataract surgery.J Cataract Refract Surg. 2001 Feb;27(2):213-8. doi: 10.1016/s0886-3350(00)00568-x. J Cataract Refract Surg. 2001. PMID: 11226784 Clinical Trial.
-
Randomized clinical comparison of Healon GV and Viscoat.J Cataract Refract Surg. 1999 Dec;25(12):1630-6. doi: 10.1016/s0886-3350(99)00244-8. J Cataract Refract Surg. 1999. PMID: 10609208 Clinical Trial.
-
[Viscoelastic substances in cataract surgery. Principles and current overview].Klin Monbl Augenheilkd. 1996 Aug-Sep;209(2-3):55-61. doi: 10.1055/s-2008-1035279. Klin Monbl Augenheilkd. 1996. PMID: 8992084 Review. German.
-
Physical Characteristics, Clinical Application, and Side Effects of Viscoelastics in Ophthalmology.J Curr Ophthalmol. 2024 Aug 10;35(4):313-319. doi: 10.4103/joco.joco_178_23. eCollection 2023 Oct-Dec. J Curr Ophthalmol. 2024. PMID: 39281404 Free PMC article. Review.
Cited by
-
Modelling of the Soft Shell Technique Using Computational Fluid Dynamics.Clin Ophthalmol. 2025 Apr 28;19:1427-1433. doi: 10.2147/OPTH.S520105. eCollection 2025. Clin Ophthalmol. 2025. PMID: 40321168 Free PMC article.
-
Comparison of surgical time and IOP spikes with two ophthalmic viscosurgical devices following Visian STAAR (ICL, V4c model) insertion in the immediate postoperative period.Clin Ophthalmol. 2016 Jan 27;10:207-11. doi: 10.2147/OPTH.S89487. eCollection 2016. Clin Ophthalmol. 2016. PMID: 26869754 Free PMC article.
-
Impact of Ophthalmic Viscosurgical Devices in Cataract Surgery.J Ophthalmol. 2020 Oct 20;2020:7801093. doi: 10.1155/2020/7801093. eCollection 2020. J Ophthalmol. 2020. PMID: 33133677 Free PMC article. Review.
-
Addition Of D-Sorbitol Improves The Usability Of Ophthalmic Viscosurgical Devices.Clin Ophthalmol. 2019 Sep 23;13:1877-1885. doi: 10.2147/OPTH.S218675. eCollection 2019. Clin Ophthalmol. 2019. PMID: 31576103 Free PMC article.
-
Intraocular lens implantation without the use of ophthalmic viscosurgical device.Int Ophthalmol. 2017 Feb;37(1):25-30. doi: 10.1007/s10792-016-0211-x. Epub 2016 Mar 14. Int Ophthalmol. 2017. PMID: 26975401
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials